Annals Internal Medicine, Author Interviews, Clots - Coagulation, Heart Disease / 27.02.2019
Equation Predicts Bleeding Risk of Aspirin for Prevention of Cardiovascular Disease
MedicalResearch.com Interview with:
Dr Vanessa Selak, MBChB, MPH, PhD, FAFPHM, FNZCPHM
Senior Lecturer, Section of Epidemiology & Biostatistics
School of Population Health
Faculty of Medical and Health Sciences
University of Auckland
MedicalResearch.com: What is the background for this study?
Response: In order to determine the balance of benefits and harms of aspirin in primary prevention there’s a need to know an individual’s risk of CVD and their risk of a major bleed without aspirin.
We have lots of equations that can be used to determine, among people considering aspirin for primary prevention, an individual’s risk of CVD, but few bleeding risk equations that can be used to determine their risk of a major bleed.
We sought to develop a bleeding risk equation that can be used to determine the risk of a major bleed among people in whom aspirin is being considered for the primary prevention of CVD. (more…)